PortfoliosLab logo
SRTS vs. IRMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SRTS and IRMD is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

SRTS vs. IRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sensus Healthcare, Inc. (SRTS) and IRadimed Corporation (IRMD). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

SRTS:

-0.19

IRMD:

1.17

Sortino Ratio

SRTS:

0.11

IRMD:

1.89

Omega Ratio

SRTS:

1.02

IRMD:

1.23

Calmar Ratio

SRTS:

-0.22

IRMD:

1.75

Martin Ratio

SRTS:

-0.57

IRMD:

4.27

Ulcer Index

SRTS:

28.45%

IRMD:

9.06%

Daily Std Dev

SRTS:

66.84%

IRMD:

32.66%

Max Drawdown

SRTS:

-87.51%

IRMD:

-75.83%

Current Drawdown

SRTS:

-68.47%

IRMD:

-7.22%

Fundamentals

Market Cap

SRTS:

$77.62M

IRMD:

$734.81M

EPS

SRTS:

$0.11

IRMD:

$1.55

PE Ratio

SRTS:

42.91

IRMD:

37.28

PEG Ratio

SRTS:

0.00

IRMD:

4.46

PS Ratio

SRTS:

1.97

IRMD:

9.78

PB Ratio

SRTS:

1.46

IRMD:

8.16

Total Revenue (TTM)

SRTS:

$39.49M

IRMD:

$75.15M

Gross Profit (TTM)

SRTS:

$22.12M

IRMD:

$57.80M

EBITDA (TTM)

SRTS:

$2.79M

IRMD:

$22.77M

Returns By Period

In the year-to-date period, SRTS achieves a -31.79% return, which is significantly lower than IRMD's 5.72% return.


SRTS

YTD

-31.79%

1M

9.01%

6M

-44.86%

1Y

-12.92%

3Y*

-18.53%

5Y*

9.49%

10Y*

N/A

IRMD

YTD

5.72%

1M

8.42%

6M

8.01%

1Y

37.76%

3Y*

21.69%

5Y*

21.60%

10Y*

11.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sensus Healthcare, Inc.

IRadimed Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

SRTS vs. IRMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRTS
The Risk-Adjusted Performance Rank of SRTS is 3838
Overall Rank
The Sharpe Ratio Rank of SRTS is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of SRTS is 3939
Sortino Ratio Rank
The Omega Ratio Rank of SRTS is 3939
Omega Ratio Rank
The Calmar Ratio Rank of SRTS is 3636
Calmar Ratio Rank
The Martin Ratio Rank of SRTS is 3838
Martin Ratio Rank

IRMD
The Risk-Adjusted Performance Rank of IRMD is 8484
Overall Rank
The Sharpe Ratio Rank of IRMD is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of IRMD is 8383
Sortino Ratio Rank
The Omega Ratio Rank of IRMD is 8080
Omega Ratio Rank
The Calmar Ratio Rank of IRMD is 9191
Calmar Ratio Rank
The Martin Ratio Rank of IRMD is 8383
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SRTS vs. IRMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and IRadimed Corporation (IRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current SRTS Sharpe Ratio is -0.19, which is lower than the IRMD Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of SRTS and IRMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

SRTS vs. IRMD - Dividend Comparison

SRTS has not paid dividends to shareholders, while IRMD's dividend yield for the trailing twelve months is around 1.11%.


TTM202420232022
SRTS
Sensus Healthcare, Inc.
0.00%0.00%0.00%0.00%
IRMD
IRadimed Corporation
1.11%0.82%3.54%3.53%

Drawdowns

SRTS vs. IRMD - Drawdown Comparison

The maximum SRTS drawdown since its inception was -87.51%, which is greater than IRMD's maximum drawdown of -75.83%. Use the drawdown chart below to compare losses from any high point for SRTS and IRMD.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

SRTS vs. IRMD - Volatility Comparison

Sensus Healthcare, Inc. (SRTS) and IRadimed Corporation (IRMD) have volatilities of 14.25% and 14.69%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

SRTS vs. IRMD - Financials Comparison

This section allows you to compare key financial metrics between Sensus Healthcare, Inc. and IRadimed Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M20212022202320242025
8.34M
19.51M
(SRTS) Total Revenue
(IRMD) Total Revenue
Values in USD except per share items

SRTS vs. IRMD - Profitability Comparison

The chart below illustrates the profitability comparison between Sensus Healthcare, Inc. and IRadimed Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%20212022202320242025
52.2%
76.1%
(SRTS) Gross Margin
(IRMD) Gross Margin
SRTS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Sensus Healthcare, Inc. reported a gross profit of 4.35M and revenue of 8.34M. Therefore, the gross margin over that period was 52.2%.

IRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, IRadimed Corporation reported a gross profit of 14.84M and revenue of 19.51M. Therefore, the gross margin over that period was 76.1%.

SRTS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Sensus Healthcare, Inc. reported an operating income of -2.65M and revenue of 8.34M, resulting in an operating margin of -31.7%.

IRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, IRadimed Corporation reported an operating income of 5.43M and revenue of 19.51M, resulting in an operating margin of 27.8%.

SRTS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Sensus Healthcare, Inc. reported a net income of -2.57M and revenue of 8.34M, resulting in a net margin of -30.8%.

IRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, IRadimed Corporation reported a net income of 4.69M and revenue of 19.51M, resulting in a net margin of 24.0%.